AMGEN V. EXCIVA
Jan 17, 2018OUTCOME: PENDING
TRADEMARK Opposition Number 91239011
Sreenivasarao Vepachedu's Legal Cases (17)
VERNON HILLS, IL
Intellectual property Lawyer at VERNON HILLS, IL
Practice Areas: Intellectual Property, Trademark Application ... +4 more
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
Apr 19, 2011OUTCOME: Grant
The present invention relates to compounds, pharmaceutical compositions, and related methods for the treatment or prevention of various diseases such as diabetes, obesity, and metabolic syndrome.
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)
Mar 15, 2011OUTCOME: Grant
Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)
Amyloid .beta.(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
Mar 08, 2011OUTCOME: Granted
Amyloid .beta.(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Feb 01, 2011OUTCOME: Grant
7,880,001 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Dec 21, 2010OUTCOME: Grant
7,855,308 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Modulators and modulation of the interaction between RGM and Neogenin
Aug 10, 2010OUTCOME: Grant
7,771,952 Modulators and modulation of the interaction between RGM and Neogenin
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Jun 15, 2010OUTCOME: Grant
7,737,137 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Inhibitors of the 11-.beta.-hydroxysteroid dehydrogenase type 1 enzyme
Feb 16, 2010OUTCOME: Grant
Inhibitors of the 11-.beta.-hydroxysteroid dehydrogenase type 1 enzyme
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
May 05, 2009OUTCOME: Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
